UK health authorities have launched a vaccination campaign offering free meningitis B protection to approximately one million young people across England. The initiative follows a significant outbreak in the Kent region earlier in the year that resulted in 29 confirmed or suspected cases and two deaths, which officials characterized as unprecedented and explosive in nature.
Vaccination eligibility includes young people born between 1 September 2007 and 31 August 2008, as well as individuals born on or after 21 July 2001 who are beginning university or residential further education for the first time. Those under age 25 can receive the vaccine through walk-in services at participating pharmacies without requiring prior GP registration. Seventeen and 18-year-olds can make bookings through the NHS National Booking Service if already registered with a doctor. Nearly 90,000 doses have been administered to date, with 135,000 additional appointments scheduled for the coming weeks.
The meningitis B vaccine is administered in two doses spaced at least 28 days apart, both of which are necessary for optimal protection. Common side effects include injection site reactions and mild symptoms such as fever or headache, which typically resolve within one or two days. Serious adverse effects remain rare. The vaccine contains no live bacteria and cannot cause meningitis itself.
Meningitis B infection can trigger severe complications including meningitis and sepsis, potentially resulting in amputations, hearing loss, brain damage, or death. Research indicates that young adults entering residential university settings face approximately seven times higher risk of infection compared to peers not attending university, primarily due to increased social mixing and shared living arrangements. Meningitis is transmitted through close contact such as kissing, sharing drinks, or vaping devices.
The MenB vaccine was incorporated into the NHS routine childhood immunization schedule for babies born on or after 1 July 2015, which is why teenagers and young adults aged 11 and older have not previously received it. While vaccine experts recommend the government consider offering routine MenB vaccination to all teenagers around age 15, current policy focuses on protecting those at highest risk during this targeted campaign.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI